Latest news:
FDA Announces Shift Away from Mandatory Animal Testing – BioReperia Offers a Validated, Human-Relevant Alternative
Read more

BioReperia represented at Tumor Models Nordics

Last week, BioReperia was proud to take part in the very firstTumor Models Nordic meeting in Stockholm, an event that brought together leading scientists, clinicians, and industry experts working with preclinical cancer models.

The meeting provided an excellent platform to share insights and discuss the latest advancements in tumor modeling and translational research. BioReperia contributed by showcasing our zebrafish-based tumor models and how they enable faster and more predictive cancer drug screening.

We were excited to engage in meaningful discussions about the future of personalized medicine and the role of innovative in vivo models in accelerating oncology research.

This website uses cookies

We use essential cookies to make our website work. With your consent, we also use non-essential cookies to improve the user experience and analyze website traffic. You can change your cookie settings at any time by clicking on Cookie settings..

Which cookies do you want to accept?

This website uses cookies

We use different types of cookies to optimize your experience on our website. Click on the categories below to learn more about their purposes. You can choose which types of cookies to allow and can change your settings at any time. Remember that disabling cookies may affect your experience on the website.

Which cookies do you want to accept?

These cookies are essential for the proper functioning of the website and cannot be disabled.

These cookies collect information about how you use our website. All of the data is anonymized and cannot be used to identify you.

Read more about Google's privacy policy and terms of use